Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial



Folegatti, Pedro M, Ewer, Katie J, Aley, Parvinder K, Angus, Brian, Becker, Stephan, Belij-Rammerstorfer, Sandra, Bellamy, Duncan, Bibi, Sagida, Bittaye, Mustapha, Clutterbuck, Elizabeth A
et al (show 355 more authors) (2020) Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. The Lancet, 396 (10249). 467 - 478.

Access the full-text of this item by clicking on the Open Access link.
Item Type: Article
Depositing User: Symplectic Admin
Date Deposited: 06 Oct 2020 15:06
Last Modified: 04 Nov 2020 16:11
DOI: 10.1016/s0140-6736(20)31604-4
Open Access URL: https://doi.org/10.1016/S0140-6736(20)31604-4
URI: http://livrepository.liverpool.ac.uk/id/eprint/3103769